anmelden
AstraZeneca Aktie
139,30
EUR
-0,95
EUR
-0,68
%
156,90
USD
-0,80
USD
-0,51
%
AstraZeneca jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Marktkap. 219,59 Mrd. EUR
KGV 27,55 Div. Rendite 1,71%WKN 886455
ISIN GB0009895292
Symbol AZN
AI Analyse
Werbung
AstraZeneca Aktie Analyse
| 19.04.21 | AstraZeneca buy | UBS AG | |
| 14.04.21 | AstraZeneca buy | UBS AG | |
| 08.04.21 | AstraZeneca Outperform | Credit Suisse Group | |
| 07.04.21 | AstraZeneca Outperform | Credit Suisse Group | |
| 07.04.21 | AstraZeneca buy | UBS AG | |
| 26.03.21 | AstraZeneca buy | UBS AG | |
| 23.03.21 | AstraZeneca buy | UBS AG | |
| 22.03.21 | AstraZeneca overweight | Barclays Capital | |
|
Werbung
|
|||
| 18.03.21 | AstraZeneca buy | Deutsche Bank AG | |
| 16.03.21 | AstraZeneca buy | Jefferies & Company Inc. | |
| 08.03.21 | AstraZeneca buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 08.03.21 | AstraZeneca kaufen | Barclays Capital | |
| 02.03.21 | AstraZeneca buy | UBS AG | |
| 25.02.21 | AstraZeneca buy | UBS AG | |
| 16.02.21 | AstraZeneca buy | Deutsche Bank AG | |
| 15.02.21 | AstraZeneca buy | Deutsche Bank AG | |
| 12.02.21 | AstraZeneca buy | Deutsche Bank AG | |
| 12.02.21 | AstraZeneca Outperform | Credit Suisse Group | |
| 11.02.21 | AstraZeneca overweight | Barclays Capital | |
| 10.02.21 | AstraZeneca buy | Deutsche Bank AG | |
| 03.02.21 | AstraZeneca buy | Deutsche Bank AG | |
| 01.02.21 | AstraZeneca buy | Deutsche Bank AG | |
| 22.01.21 | AstraZeneca overweight | Barclays Capital | |
| 20.01.21 | AstraZeneca Outperform | Credit Suisse Group | |
| 15.01.21 | AstraZeneca buy | Deutsche Bank AG | |
| 15.01.21 | AstraZeneca buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 14.12.20 | AstraZeneca buy | Kepler Cheuvreux | |
| 14.12.20 | AstraZeneca Outperform | Credit Suisse Group | |
| 14.12.20 | AstraZeneca buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 07.12.20 | AstraZeneca overweight | Morgan Stanley | |
| 04.12.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 23.11.20 | AstraZeneca overweight | Barclays Capital | |
| 23.11.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 23.11.20 | AstraZeneca buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 19.11.20 | AstraZeneca buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 10.11.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 06.11.20 | AstraZeneca Outperform | Credit Suisse Group | |
| 05.11.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 02.11.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 08.10.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 29.09.20 | AstraZeneca buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 29.09.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 18.09.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 10.09.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 09.09.20 | AstraZeneca overweight | Barclays Capital | |
| 08.09.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 31.07.20 | AstraZeneca Outperform | Credit Suisse Group | |
| 30.07.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 29.07.20 | AstraZeneca overweight | Barclays Capital | |
| 28.07.20 | AstraZeneca Outperform | Credit Suisse Group | |
Werbung
Werbung
